Siparex

Siparex operates eight distinct investment strategies under one parent group, covering the full equity lifecycle from early-stage venture and growth capital to mid-cap buyouts, management buy-ins, and turnaround situations. The platform is run from Lille and distributed across 10 offices in France and Europe. It is an independent asset manager, not attached to a single-family pool or banking group.

Siparex concentrates on France and continental Europe, with offices in Paris, Lyon, Nantes, Lille, Strasbourg, Toulouse, Milan, Berlin, and Brussels. The group also maintains partnership links into Tunisia and Canada. Its portfolio companies frequently execute cross-border European expansion, as seen with Passman Group's UK acquisition and WVT Group's biocon growth across the continent.

Siparex makes direct investments across its strategies. Its midcap team takes majority positions in companies like Groupe Corali, while venture and growth strategies target minority and control stakes depending on stage. The firm does not publicly market a fund-of-funds vehicle, and its materials describe a hands-on transformation team embedded alongside investment professionals.

The group runs dedicated strategies for startup and early-stage venture, expansion and late-stage growth, management buy-ins, management buyouts, restructuring, and turnaround. This multi-stage approach means a single platform can back a company from its seed round through to a mid-cap buyout or restructuring, though each strategy team operates independently.

Siparex states that it has integrated extra-financial dimensions into investment selection since its origin, operating under an ethical and engaged vision of the investor's role. A dedicated 'Moving for the Planet' section and responsible-investor positioning appear on its website. Specific regulatory classifications, exclusions, or reporting frameworks are not disclosed publicly.